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Abstract
Background: Control of the sea louse Caligus rogercresseyi in the Chilean salmonid industry is reliant on chemical
treatments. Azamethiphos was introduced in 2013, although other organophosphates were previously used. In
2014, reduced sensitivity to azamethiphos was detected in the Los Lagos Region using bioassays. The main target
of organophosphates is the enzyme acetylcholinesterase (AChE). Mutations in the AChE gene are the main cause of
organophosphate resistance in arthropods, including other sea lice. In the present study, we aimed to characterize
C. rogercresseyi AChE(s) gene(s) and to study the association between AChE variants and azamethiphos resistance in
this sea louse species.
Methods: Samples of adult male and female C. rogercresseyi were collected in the Los Lagos Region in 2014.
Twenty-four hour exposure bioassays with azamethiphos were performed to select sensitive and resistant lice. The
full-length cDNA coding sequences encoding for two AChEs in C. rogercresseyi were molecularly characterized. One
of the AChE genes was screened by direct sequencing in the azamethiphos-selected lice to search for variants. An
additional louse sampling was performed before and after an azamethiphos treatment in the field in 2017 to
validate the findings.
Results: The molecular analysis revealed two putative AChEs in C. rogercresseyi. In silico analysis and 3D modelling
of the protein sequences identified both of them as invertebrate AChE type 1; they were named C. rogercresseyi
AChE1a and 1b. AChE1a had the characteristics of the main synaptic AChE, while AChE1b lacked some of the
important amino acids of a typical AChE. A missense change found in the main synaptic AChE (1a), F318F/V (F290
in Torpedo californica), was associated with survival of C. rogercresseyi at high azamethiphos concentrations (bioassays
and field treatment). The amino acid change was located in the acyl pocket of the active-site gorge of the protein.
Conclusions: The present study demonstrates the presence of two types of AChE1 genes in C. rogercresseyi. Although
enzymatic assays are needed, AChE1a is most probably the main synaptic AChE. The function of AChE1b is unknown,
but evidence points to a scavenger role. The AChE1a F/V318 variant is most probably involved in organophosphate
resistance, and can be a good marker for resistance monitoring.
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Background
The sea louse Caligus rogercresseyi (Copepoda, Caligidae)
is the most harmful parasite affecting the salmon farming
industry in Chile [1–3]. Heavily infested fish show physio-
logical changes due to stress, lice-induced skin lesions,
weight loss and increased susceptibility towards other
infectious diseases [4]. In addition to the economic loss
due to the damage inflicted to fish, salmon producers
must face the additional cost of anti-lice treatments. Cali-
gus rogercresseyi has a wide host range, parasitizing both
wild and farmed fish (reviewed in [5]). Its direct life-cycle
facilitates the transmission between hosts, especially in
densely reared fish [5].
Control of C. rogercresseyi infestations in Chilean fish
farms depends mainly on the use of anti-lice chemicals
(reviewed in [6, 7]). The organophosphates metrifonate and
dichlorvos (applied by bath) were used during the period
1981–2000 [8]. Between 2000 and 2007, the only anti-lice
chemical authorized in Chile was the avermectin emamec-
tin benzoate [9, 10]. Reduction in treatment efficacy by
emamectin benzoate was first detected in 2006–2007 [9–
11]. Pyrethroids were introduced (deltamethrin in 2007 and
cypermethrin in 2010) to cope with the resistance problem
of C. rogercresseyi towards emamectin benzoate. Pyre-
throids became the main anti-lice chemical agents in use
until 2013, when treatment failures due to pyrethroid-re-
sistant parasites were reported [12]. In order to control C.
rogercresseyi loads in salmonid farms, the organophosphate
azamethiphos was introduced in 2013 [7]. Since then, aza-
methiphos is the most utilized anti-lice chemical in Chilean
salmonid farming [13].
Sea lice resistance towards the main anti-lice chemicals
has been recorded in most salmonid producing countries.
Organophosphate-resistant salmon lice, Lepeophtheirus
salmonis, have been found in Scotland, Norway and
Ireland [14–17]. Reduced sensitivity of C. rogercresseyi
towards azamethiphos has been reported recently in some
salmonid production areas in Chile [7, 18]. Agusti et al.
[7] showed that azamethiphos treatment efficacy for adult
C. rogercresseyi ranged between 92 and 100% in four farms
located in Los Lagos and Aysén Regions (commonly
known as Regions X and XI, respectively). However, when
lice sensitivity to azamethiphos was tested in Los Lagos
Region by the use of bioassays, Agusti et al. [7] reported
EC50 values (the concentration immobilizing 50% of the
parasites) between eight and fifteen times higher than the
C. rogercresseyi putative naïve level (sensitivity of lice
never exposed to an anti-louse chemical). Marín et al. [18]
also observed reduced sensitivity of C. rogercresseyi to aza-
methiphos in several farms in Los Lagos and Aysén
Regions, and found that lice from Los Lagos Region
tended to be less sensitive to azamethiphos than
those from Aysén Region. Agusti et al. [7] suggested
the previous (1981–2001) and present (2013–2016)
use of organophosphates as the possible cause for the
reduced sensitivity observed in Los Lagos Region.
Due to the incipient resistance development in C. roger-
cresseyi to azamethiphos, an accurate time-space monitor-
ing of the sensitivity level to this chemical is highly
necessary. Currently, bioassays are the only available
method for measuring C. rogercresseyi sensitivity in Chile
[7, 12, 18]. In these assays, live sea lice are exposed to a
range of chemical concentrations for a given time. Follow-
ing the exposure, the number of dead or immobilized par-
asites is registered [19]. However, bioassays are laborious
to conduct and subject to several potential methodological
and interpretation errors (discussed in [20, 21]). Molecular
methods have demonstrated to be a powerful tool for
monitoring the sensitivity of sea lice to chemicals [22, 23].
However, it is important to elucidate the molecular mech-
anisms behind the resistance for developing such a tool.
Mutations in the gene coding for the enzyme acetyl-
cholinesterase (AChE) have been reported as the main
cause of resistance towards organophosphates in arthro-
pods, followed by metabolic and behavioural mechanisms
(discussed in [21, 24–28]). AChE is present in the cholin-
ergic synapses of the nervous system of arthropods and in
the neuromuscular junctions of vertebrates [29]. It hy-
drolyses the neurotransmitter acetylcholine, assuring the
correct functioning of neurotransmission. Organophos-
phates inhibit AChE, causing the accumulation of acetyl-
choline in the synapses (reviewed in [24, 25, 28, 30]). This
results in overstimulation of nerves and muscles, leading
to paralysis and death of the parasite. Kaur et al. [21, 22]
found that a single amino acid mutation (F362Y, corre-
sponding to Phe331 in Torpedo californica AChE) in the
active-site gorge of the synaptic AChE was the major
factor responsible for organophosphate resistance in L.
salmonis. Based on those findings, a rapid and reliable
assay was developed for screening the mutation in
field samples, providing a valuable tool for salmon
louse resistance monitoring [21, 22].
The main aim of the present study was to identify and
characterize the AChEs present in adult C. rogercresseyi col-
lected in Chilean salmonid farms. In order to explore the
possible causes for the loss of sensitivity to azamethiphos in
some louse populations, the gene coding for the synaptic
AChE enzyme (C. rogercresseyi AChE1a) was screened for
variants in sensitive and resistant lice.
Methods
Sea lice sampling and selection
Caligus rogercresseyi individuals were collected at two-
time points: during March 2014 and June 2017. Three
sampling sites were chosen based on the availability of
lice in farms in Los Lagos Region and the suspected dif-
ferent lice sensitivities to azamethiphos [7, 18]. The
number of treatments applied in each farm and the
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treatment efficacies were used as an indicator for farm
selection, since low lice sensitivity seems to be related
with high number of treatments and low treatment effi-
cacies [7, 23]. The farms selected were located in the
north and middle part of the interior sea in Los Lagos
Region (Fig. 1). During the year before the lice were col-
lected, Farm 1 conducted two azamethiphos treatments
and Farm 2 seven treatments before March 2014; Farm 3
conducted four azamethiphos treatments before lice sam-
pling in June 2017. All farms were stocked with a single
year-class of fish. Farms 1 and 3 reared Atlantic salmon
and Farm 2 reared rainbow trout. Fish were sampled using
a dip net and anesthetized for louse collection.
Bioassays were conducted on lice collected in Farms
1 and 2 during March 2014 in order to assess the ac-
tual lice sensitivity to azamethiphos and for a proper
selection of sensitive versus resistant lice. Lice used
for bioassays were all adult males and females, but
differences in the maturation level of the genital seg-
ment were observed. Bioassays were carried out as
described by Agusti et al. [7], Helgesen et al. [12] and
Helgesen & Horsberg [19]. Caligus rogercresseyi were
gently removed from the anesthetized fish using for-
ceps. They were kept alive at low temperature in con-
tainers with seawater supplied with aeration until the
start of the bioassay. Sea lice were exposed to aza-
methiphos for 24 h at 12 °C with constant aeration,
and the results were recorded immediately following
the exposure time. Two types of bioassays were de-
signed depending on the number of azamethiphos di-
lutions used and the purpose of the bioassay. For
sensitivity assessment (and lice selection), four to five
azamethiphos dilutions were prepared in filtered (100
μm filter) seawater, ranging from 0.2 to 2 ppb (μg
l-1). For lice selection only, two azamethiphos dilu-
tions were used: 0.4 and 2 ppb. Lice immobilized (un-
able to attach to the walls of the containers or swim
actively) at 0.4 ppb or below, were considered sensi-
tive, while lice unaffected at 2 ppb were considered
resistant [7, 19, 22, 23]. Immediately following the 24
h exposure, lice were fixed in RNAlater® (Sigma--
Merck KGaA, Darmstadt, Germany; item number
R0901) and kept at -80 °C. Control groups without
azamethiphos were prepared to determine the general
performance of the lice. Bioassays were initiated
within 2–6 h of sampling the first louse. Data from
four to five dose bioassays were modelled using probit
modelling in JMP software, and EC50 values with 95%
confidence intervals were calculated separately for
males and females.
Fifty-seven additional lice were collected in June 2017
before and after an azamethiphos treatment event in
Farm 3. Pre-treatment louse sampling was performed
one day before the treatment. Thirty adult lice (12 males
and 18 females) were collected from five fish during the
pre-treatment sampling. The azamethiphos treatment
was applied by bath at a concentration of 0.1 g/m3 for
50 min. The post-treatment sampling occurred three
days after treatment, lice being collected from the same
cage as the pre-treatment sampling. Twenty-eight adult
lice (20 males and 8 females) were recovered after treat-
ment from 20 fish. Lice were gently removed from the
anesthetized fish using forceps and were transferred dir-
ectly to RNAlater® for fixation and preservation.
Fig. 1 Farm locations where Caligus rogercresseyi were collected in March 2014 (Farms 1 and 2) and in June 2017 (Farm 3). Map displays the
interior sea in Los Lagos Region (Region X)
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RNA extraction and cDNA synthesis
Total RNA was extracted from the whole body (lice from
Farms 1 and 2; bioassays) or only from the cephalotorax
(lice from Farm 3; pre-post azamethiphos treatment) of
adult C. rogercresseyi females and males. A Trizol protocol
combined with the RNeasy Mini kit for animal tissues (Qia-
gen, Hilden, Germany) was used for the extraction. Lice tis-
sues were homogenized in 1 ml Trizol using TissueLyser
MM 301 (Qiagen Retsch, Hilden, Germany) and one stain-
less steel bead of 5 mm diameter (Qiagen). After mixing
with 0.2 ml chloroform and a centrifugation step, the aque-
ous phase was transferred to a new vial and mixed with
one volume of 70% ethanol. Total RNA was then isolated
with RNeasy spin columns following the manufacturer’s
protocol. The RNA was quantified with an ND-100 Spec-
trophotometer (Thermo Fisher Scientific, Waltham, Massa-
chusetts, USA) and the quality was checked with a 2100
Bioanalyzer instrument (Agilent Technologies, Santa Clara,
California, USA) and an Agilent RNA 6000 Nano kit. First
strand cDNA was synthesized with the RevertAid H Minus
first strand cDNA synthesis kit (Thermo Fisher Scientific)
using oligo (dT)18 primers.
Identification and characterization of C. rogercresseyi
AChEs
In order to identify C. rogercresseyi AChE sequences, a
search against the C. rogercresseyi transcriptome [31] was
conducted using the two types of AChEs in L. salmonis
(ace1a and ace1b) as queries. The search was performed
using blastn optimized for discontiguous megablast [32].
To verify and properly characterize the C. rogercresseyi se-
quences obtained, the cDNA sequences were used for
searching against the C. rogercresseyi Whole-Genome
Shotgun Contigs (WGS) [33] (blastn, megablast, NCBI
[32]). The cDNA and genomic sequences were assembled
using ContigExpress software (Vector NTI Advance 11.0,
Invitrogen Corp. 2008). The sequences obtained were
amplified and analyzed on a subset of lice enrolled in the
bioassay analysis (n = 10). The PCR cycling conditions
were as follows: 98 °C for 2 min followed by 35 cycles of
amplification at 98 °C for 10 s, 62 °C or 67 °C for 15 s (see
Additional file 1 for primer annealing temperature), 72 °C
for 2 min and a final extension step at 72 °C for 5 min.
The primers selected were located in the putative untrans-
lated 5' and 3' regions (UTRs) and are listed in Additional
file 1. The Phusion® High-Fidelity DNA Polymerase (New
England BioLabs, Ipswich, Massachusetts, USA) was uti-
lized. Amplicons were subjected to direct sequencing
using several internal primers (Additional file 1) (GATC
Biotech, Constance, Germany; Sanger sequencing service,
Supremerun sequencing).
In silico analysis of the deduced C. rogercresseyi AChE
protein sequences were performed as follows. Database
searches of the sequences were conducted against several
databases in order to verify the identity of the proteins:
GenBank (non-redundant protein sequences - nr, BlastP),
UniProtKB (BlastP; default settings) and InterProScan se-
quence search (default settings). In addition, the deduced
proteins were compared to previously published AChE pro-
tein sequences from another 19 species, using the ClustalO
program [34] with default settings to obtain a multiple
sequence alignment (MSA). The following online modelling
platforms were used for predicting the presence of trans-
membrane helices in C. rogercresseyi AChEs: SOSUI [35,
36], TMHMM Server v.2.0 [37–39] and DAS [40, 41].
A phylogenetic analysis of the putative C. rogercresseyi
AChEs was performed. Several cholinesterase (ChE) types
from vertebrates and invertebrates were included.
Full-length ChE sequences were found by: (i) BlastP
searches of the GenBank-nr and UniprotKB databases
using the C. rogercresseyi AChE sequences identified in
this study as queries; and (ii) searching for complete se-
quences in the UniprotKB database, using keywords as
queries (“acetylcholinesterase”, “cholinesterase”, “ace”,
“AChE”, etc.). MSA was generated with MUSCLE [42]
with default parameters. MSA was manually inspected
and edited in Jalview [43] removing regions of low cover-
age, low alignment quality, and a complete sequence
introducing large gaps (Gallus gallus AChE). Phylogenetic
trees were constructed using MrBayes v.3.2.6 x64 [44]
using 8 parallel chains over a total of 5 million genera-
tions; rates were approximated by a Γ-distribution with 4
categories, allowing for invariant sites. Markov Chain
Monte Carlo (MCMC) analysis was run in mixed mode
[45] to allow MrBayes to determine the optimal substitu-
tion matrix, resulting in a WAG+I+Γ model. In addition,
the MSA was submitted to ProtTest server [46] to deter-
mine the optimal substitution model and MrBayes was
run again using the best-fit LG+I+Γ model. The vertebrate
taxa were used as out-group to root the trees.
To further explore the identity of C. rogercresseyi AChE
sequences, another phylogenetic analysis was performed
with the same parameters. The analysis included
sequences of several invertebrate and vertebrate carboxy-
lesterases, esterases and other cholinesterases available in
the UniprotKB database.
3D modelling of C. rogercresseyi AChEs and docking
analysis
The three-dimensional (3D) structure of the C. roger-
cresseyi AChEs was modelled using SWISS MODEL in
the automated mode [47–49]. For a better search of
templates, a number of amino acids at each end of the
C. rogercresseyi AChEs sequences were truncated fol-
lowing a similar pattern as in Drosophila melanogaster
and Homo sapiens AChE [Protein Data Bank (PDB)
codes 1qo9.1 and 4ey4.1, respectively]. In short, the
AChEs sequences were aligned using ClustalO program
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with default settings. The amino acids at the beginning
and/or the end of the C. rogercresseyi AChEs that did not
align to the other sequences were truncated. QMEAN and
GMQE (global model quality estimation) scores were used
as indicators of the quality of the models [47]. To analyze
the fit between the selected templates and the predicted C.
rogercresseyi AChEs structures, the root mean square
(RMS) values for carbon alpha (Cα) were calculated using
the Swiss PDB viewer v.4.1.0 [50]. The values were calcu-
lated for the whole protein and for the ten amino acids im-
portant for the function of the protein (the anionic choline
binding site, the catalytic triad, the acyl pocket residues
and the oxyanion hole). The numbering of amino acids is
by convention from the T. californica AChE sequence. The
3D models were visualized using UCSF Chimera v.1.10.2.
software [51]. The distances between amino acids in the
active-site gorge were calculated using the same software.
The volume of the active-site gorge of the proteins was
calculated using the software CASTp [52, 53].
Acetylcholine and two organophosphates, azamethiphos
and dichlorvos, were docked to the C. rogercresseyi AChEs
3D models using the online molecular docking server
[54, 55]. The whole active-site gorge of the proteins,
from the mouth to the bottom of the gorge, was se-
lected for performing the analysis. The results were
examined for the likely binding sites, frequency of
binding to these sites, free binding energy and the esti-
mated inhibition constant (Ki, the concentration re-
quired to produce half-maximum inhibition).
Screening of C. rogercresseyi ace1a for variants
The full cDNA coding sequence of the putative synap-
tic AChE (1a) was amplified to look for variants, using
gene specific primers (Additional file 1, “Cr_ace1a”).
The sequence was analyzed in five azamethiphos sen-
sitive, three with reduced sensitivity and two resistant
adult C. rogercresseyi selected with bioassays (Farms 1
and 2). PCR reactions were performed using Phusion®
High-Fidelity DNA Polymerase; PCR conditions and dir-
ect sequencing were performed as stated in the previous
section “Methods. Identification and characterization of C.
rogercresseyi AChEs”.
For rapid screening of the AChE1a variants in the 57
additional lice collected before and after the azamethiphos
field treatment (Farm 3, June 2017), a 484 bp fragment of
the ace1a gene containing an important missense change
was amplified. Two fragment-specific primers were de-
signed (Additional file 1, named HS4F and HS6R). PCR
reactions were performed using Phusion® High-Fidelity
DNA Polymerase under the following conditions: 98 °C
for 2 min followed by 35 cycles of amplification at 98 °C
for 10 s, 62 °C for 20 s, 72 °C for 30 s and a final extension
step at 72 °C for 5 min. Amplicons were subjected to
direct sequencing (GATC Biotech; Sanger sequencing ser-
vice, Supremerun sequencing).
Results
Sequence analysis and characterization of C. rogercresseyi
AChEs
Two partial cDNA AChE sequences were identified in C.
rogercresseyi transcriptome ([31] GenBank: GAZX01027370.1
and GAZX01029466.1). The search of these sequences
against the C. rogercresseyi WGS (female and male) re-
sulted in several contigs (see Additional file 2). The
cDNA sequence of GAZX01027370.1, identified in the
C. rogercresseyi transcriptome as a putative AChE, was
confirmed and characterized in the lice collected in the
present study (n = 10). It has an open reading frame
(ORF) of 1941 bp, encoding a deduced protein of 646
amino acids. In silico analysis of this deduced protein
identified it as an AChE with transmembrane segment.
The domains and signatures identified were: cholin-
esterase, alpha/beta hydrolase fold, carboxylesterase
type B-active site, cytoplasmic region, non-cytoplasmic
region, transmembrane region and several signal pep-
tides. The amino acid alignment of this C. rogercresseyi
putative AChE with 19 AChE sequences from other
species (Crustacea, Insecta, Nematoda, Arachnida and
Vertebrata) revealed that it has the characteristic fea-
tures of the main synaptic AChE (Fig. 2 and Additional
file 3) [56]. These features include: the anionic choline
binding site (W84, numbering corresponds to T. cali-
fornica AChE), the three residues of the catalytic triad
(S200, E327 and H440), the characteristic FGESAG
motif surrounding the active serine, the acyl pocket res-
idues (W233, F290 and F331), the oxyanion hole (G118,
G119 and A201) and six cysteines involved in the three
conserved disulphide bonds (C67-C94, C254-C265,
C402-C521). Three online modeling platforms (SOSUI,
TMHMM Server v.2.0 and DAS; see Methods for de-
tails) identified a hydrophobic C-terminal peptide in
this C. rogercresseyi AChE as a transmembrane helix,
between the amino acids 604 and 626 (C. rogercresseyi
AChE numbering) (Fig. 3). The alignment of C. roger-
cresseyi AChE with L. salmonis AChE1a revealed a high
identity between them (85.3%), while the identity per-
centage with L. salmonis AChE1b was 77.2%. This
alignment also identified the putative C. rogercresseyi
AChE hydrophobic peptide in a similar position as in L.
salmonis AChE1a (Fig. 3), and the most probable cleav-
age site of the C. rogercresseyi AChE hydrophobic pep-
tide in the cysteine residue C595 (also C595 in L.
salmonis) (Fig. 3). Based on these observations, we con-
cluded that this C. rogercresseyi AChE could be the
main synaptic enzyme.
When the other cDNA sequence, GAZX01029466.1
(preliminarily identified as another AChE in the C.
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Fig. 2 Alignment of the deduced amino acid sequence of Caligus rogercresseyi AChE1a and AChE1b with 19 previously published acetylcholinesterases
(AChE) from other arthropods and vertebrates. The ten important amino acids and several cysteines involved in disulphide bridges are
indicated by arrows (also highlighted in bold in Torpedo californica and Caligus rogercresseyi sequences, in blue and red, respectively). The
red box represents the canonical “FGESAG” motif, characteristic of the active site of cholinesterases. The blue box represents the typical
sequence insertion/deletion domain that distinguishes AChE1 and 2. Abbrevations: An_ga, Anopheles gambiae; Ap_me, Apis mellifera; Bl_ge,
Blattella germanica; Ca_el, Caenorhabditis elegans; Ca_ro, Caligus rogercresseyi; Dr_me, Drosophila melanogaster; Ho_sa, Homo sapiens; Le_sa,
Lepeophtheirus salmonis; Mu_do, Musca domestica; Ne_ci, Nephotettix cincticeps; Rh_de, Rhipicephalus decoloratus; Te_ur, Tetranychus urticae;
Ti_ja, Tigriopus japonicus; To_cal, Torpedo californica. For UniprotKB database entry names see Additional file 3
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rogercresseyi transcriptome), is translated into protein,
the putative start codon is located only 22 bp from the
beginning of the sequence. We searched in the C. roger-
cresseyi WGS to obtain a longer 5' end fragment of the
sequence. The search resulted in five genome contigs
overlapping with the cDNA sequence (Additional file 2).
The GAZX01029466.1 sequence was assembled with the
genome contigs obtained in the blast analysis. The con-
sensus sequence increased the putative 5' end by 279
additional bp. Primers were then designed in the new
putative untranslated 5' region (UTR) and in the 3' re-
gion (Additional file 1, “Cr_ace1b”). The PCR product
obtained using those primers revealed a transcript lon-
ger than the consensus sequence obtained from the as-
sembling of GAZX01029466.1 and the genome contigs,
since a completely new fragment of 484 bp was found.
This fragment comprises 440 bp belonging to the 5'
UTR and 44 bp to the beginning of the coding
sequence, containing the “atg” start codon. The new
transcript has an ORF of 1689 bp, encoding a deduced
protein 562 aa long. The new 5' UTR is at least 776 bp
long. The sequence was submitted to the GenBank
database under the accession number MF978386. In
silico analysis of the deduced protein revealed that it
probably was an AChE without transmembrane segment.
The domains and signatures identified were: cholinester-
ase, alpha/beta hydrolase fold and carboxylesterase type B;
no cytoplasmic or transmembrane regions were identified.
When the putative protein sequence was aligned with 19
AChE sequences from other species, only some of the fea-
tures of a typical AChE were identified (Fig. 2): it has the
anionic choline binding site (W84), the oxyanion hole
(G118, G119 and A201) and six cysteine residues involved
in three conserved disulphide bonds (C67-C94, C254-
C265, C402-C521). However, all three residues of the cata-
lytic triad and two residues of the acyl pocket are
substituted by other amino acids, and it lacks the charac-
teristic FGESAG motif. The three online modeling plat-
forms used for predicting the presence of transmembrane
helices (SOSUI, TMHMM Server v. 2.0 and DAS), pre-
dicted this protein to be soluble, without hydrophobic
peptide. In addition, no free cysteine residue (the potential
cleavage site of a hydrophobic peptide) is present in the
C-terminal of the protein (Fig. 3), as is the case in L. sal-
monis AChE1b. The most similar proteins identified were
L. salmonis AChE1a (54.9%) and AChE1b (54.9%). It
shares 54% similarity with the other AChE described
above for C. rogercresseyi.
Phylogenetic analysis (Fig. 4 and Additional files 3 and 4)
showed that the two putative C. rogercresseyi AChE se-
quences cluster together with the AChE type 1 occurring
in crustaceans and insects, being clearly separated from the
AChE type 2 group. Based on this finding, the protein de-
duced from the GAZX01027370.1 sequence will be here-
after referred to as C. rogercresseyi AChE1a, and the
protein deduced from the new sequence generated on basis
of GAZX01029466.1, as C. rogercresseyi AChE1b. Caligus
rogercresseyi AChE1a grouped together with both L. salmo-
nis AChEs in the phylogenetic tree. Caligus rogercresseyi
AChE1b appeared in the crustacean AChE type 1 cluster,
but with a large genetic distance. The inclusion of several
invertebrate and vertebrate carboxylesterases, esterases and
other cholinesterases did not change the position of C.
rogercresseyi AChE1b in the tree (Additional file 4).
Bioassays and field treatment with azamethiphos
Bioassays with 24 h exposure time were performed to de-
termine the lice sensitivity towards azamethiphos, at the
population and individual levels. In Farms 1 and 2, one 5/
6-dose bioassay was performed per farm. The lice sensitiv-
ity level to azamethiphos, expressed as EC50 values with
95% confidence intervals, was 0.48 ppb (0.09–2.50) for
males and 0.51 ppb (0.26–0.99) for females in Farm 1, and
1.20 ppb (1.19–1.22) for both males and females in Farm
2. In addition, a 3-dose bioassay for lice selection was con-
ducted in Farm 2. Table 1 summarizes the immobilization
data of C. rogercresseyi exposed to different azamethiphos
concentrations per farm.
Fig. 3 Alignment of Caligus rogercresseyi (Ca_ro) and Lepeophtheirus salmonis (Le_sa) C-terminus of AChE1a and AChE1b. The site of cleavage
(cysteine) of the putative hydrophobic peptide (C595 in both louse species) is shown in bold, red and underlined. The hydrophobic C-terminal
peptide in both species is in italics, bold and underlined
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An azamethiphos field treatment in Farm 3 was used
for testing the association of an important missense
change found in ace1a with C. rogercresseyi sensitivity
loss towards azmethiphos. Male and female lice col-
lected before the treatment were adults with the geni-
tal segment completely developed (“mature” following
the terminology by González & Carvajal [5]), and
some females carried egg strings. Treatment efficacy
in the sampling cage was 97% for adult lice and 57%
for chalimus stages. After the treatment, only ten adult
males with fully developed genital segments (mature)
were recovered on the fish analysed (n = 20), for the
rest of the adult males (n = 10) and all the adult
females (n = 8) the genital segments were not fully de-
veloped (“young adult lice” following the terminology
by González & Carvajal [5]).
Screening of C. rogercresseyi AChE1a for variants
The screening and alignment of the full cDNA coding
sequence encoding for C. rogercresseyi AChE1a in five
sensitive (immobilized at 0.4 ppb or below), three with
reduced sensitivity (unaffected at 1.2 ppb) and two
Fig. 4 Phylogenetic analysis including Caligus rogercresseyi AChE1a and AChE1b together with several cholinesterases from vertebrates (blue box)
and invertebrates. Caligus rogercresseyi AChE1a and 1b are shown in a yellow box together with other crustacean AChEs. For abbrevations and
UniprotKB database entry names see Additional file 3
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resistant (unaffected at 2 ppb) adult C. rogercresseyi, re-
vealed several synonymous and two non-synonymous
changes. Additional file 5 shows the alignment of the
cDNA sequences in the ten C. rogercresseyi individuals.
One of the two non-synonymous changes found in
ace1a was thymine to guanine at position 952 (T952G).
This change led to an amino acid change: phenylalanine
(F) to valine (V) at codon 318 (C. rogercresseyi AChE1a
numbering). Among the ten C. rogercresseyi individuals
analyzed, the F318V change was found in the two lice
unaffected at 2 ppb (resistant) and in one louse immo-
bilized at 0.4 ppb (see Table 2 for details). These three
lice carrying the change were heterozygous for the
variant (F/V318). The two adult lice unaffected at 2 ppb
(resistant) did not have fully developed genital seg-
ments (“young adults”).
To investigate the importance of the F/V318 variant,
the sequence of the C. rogercresseyi AChE1a protein
was aligned with 19 AChE amino acid sequences from
other species (Fig. 2). The alignment revealed that F318
in C. rogercresseyi is homologous to F290 in the T. cali-
fornica AChE. This amino acid is located in the acyl
pocket of the protein, neighboring the catalytic center
in the active-site gorge. It is a highly conserved residue
among the species as evident from the MSA of AChEs
from several species (Fig. 2).
The other non-synonymous change found in C. roger-
cresseyi ace1a, guanine to adenine at position 82 (G82A),
led to the amino acid change valine to isoleucine at pos-
ition 28 (V28I). This change was found in only one sensi-
tive male louse and it is situated close to the N-terminus
of the protein. Valine and isoleucine are similar amino
acids with similar physical properties. In addition, when
aligning L. salmonis AChE1a, AChE1b and C. rogercresseyi
AChE1a sequences, both L. salmonis AChEs has isoleu-
cine at that same position (data not shown).
The analysis of the AChE1a fragment in the lice col-
lected before and after the azamethiphos field treatment
showed that every young adult female recovered after
treatment carried the F/V318 variant. Table 3 shows the
percentage of lice carrying the F/V318 variant in the pre-
and post-treatment sampling, separate for sex and matur-
ation level of the genital segment. All lice carrying the
change were heterozygous for the variant (F/V318).
3D modelling of C. rogercresseyi AChEs and docking analysis
The 3D structure of C. rogercresseyi AChE1a and AChE1b
was modeled using the SWISS MODEL software. An
Table 1 Immobilization percentage (%) of Caligus rogercresseyi
exposed to azamethiphos per farm using bioassays






1 0 0 (6) 0 (13)
0.2 14 (7) 0 (12)
0.4 17 (6) 42 (12)
1.2 100 (6) 91 (11)
2.0 100 (8) 100 (10)
2: Bioassay 1 0 12.5 (8) 0 (22)
0.2 0 (11) 0 (19)
0.4 0 (11) 0 (20)
0.8 0 (8) 0 (22)
1.2 42 (12) 37 (19)
2 100 (10) 100 (21)
2: Bioassay 2 0 0 (19) 0 (20)
0.4 0 (21) 0 (16)
2.0 93 (15) 93 (15)
Abbreviations: Aza azamethiphos, n, sample size for each louse sex
Table 2 Presence/absence of the F/V318 variant in Caligus rogercresseyi AChE1a selected for azamethiphos using bioassays (10 lice)
Aza dose (ppb) Bioassay output Louse sex Farm AChE1a variant
0.2 Immobilized Male 1 Homozygous F/F
0.4 Immobilized Male 1 Homozygous F/F
0.4 Immobilized Female 1 Homozygous F/F
0.4 Immobilized Female 1 Heterozygous F/V
0.4 Immobilized Female 1 Homozygous F/F
1.2 Unaffected Female 2 Homozygous F/F
1.2 Unaffected Female 2 Homozygous F/F
1.2 Unaffected Female 2 Homozygous F/F
2.0 Unaffected Female (younga) 2 Heterozygous F/V
2.0 Unaffected Male (younga) 2 Heterozygous F/V
aYoung adult: adult lice without fully developed genital segments [5]
Lice immobilized at 0.2 and 0.4 ppb were considered sensitive, lice unaffected at 1.2 ppb were considered with reduced sensitivity and lice unaffected at 2
ppb, resistant
Abbreviation: Aza azamethiphos
Lice carrying the variant are highlighted in bold
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initial template search revealed several possible templates.
The 3D model giving high QMEAN and GMQE scores in
the template search for C. rogercresseyi AChE1a was the
crystal structure of recombinant human AChE in the apo
state (PDB code 4ey4.1) (Table 4). Native D. melanogaster
AChE (PDB code 1qo9.1) gave lower GMQE and
QMEAN values than human AChE as template (Table 4).
Drosophila melanogaster AChE is the only arthropod
AChE which crystalline 3D structure has been solved to
date [57]. Since C. rogercresseyi is also an arthropod, D.
melanogaster AChE is expected to be a relatively good
template for predicting the 3D structure of C. rogercresseyi
AChE1a. However, they belong to different AChE types,
D. melanogaster AChE belonging to type 2 and C. roger-
cresseyi AChE to type 1 (see Fig. 4), which could explain
the low GMQE and QMEAN values. The RSM values
(Cα) for recombinant human AChE, the native D. melano-
gaster AChE and the predicted structure of C. rogercres-
seyi AChE1a (F318 and V318 variants) are shown in Table
4. Since the model quality indicators and fit values were
better for human AChE as template for the two C. roger-
cresseyi AChE1a variants than D. melanogaster AChE, hu-
man AChE 3D structure was chosen to predict both
variants of C. rogercresseyi AChE1a. For C. rogercresseyi
AChE1b, the crystal structure of fully glycosylated human
butyrylcholinesterase (BChE) was chosen (PDB code
4aqd.1) (see Table 4 for GMQE, QMEAN and RSM
values). Additional files 6, 7 and 8 contain the PDB files of
the predicted C. rogercresseyi AChE1a (F318 and V318
variants) and AChE1b 3D structures.
The 3D modeling of C. rogercresseyi AChE1a pre-
dicted a gorge containing the ten amino acids import-
ant for the function of the protein. These amino acids
were predicted in a similar position and orientation as
the corresponding amino acids in the D. melanogaster
and H. sapiens AChE templates. The predicted gorge of
C. rogercresseyi AChE1a was about 16 Å deep and 15 Å
at its widest point, close to the bottom. The entire
active-site gorge had a volume similar to the gorge of
the human AChE. The C. rogercresseyi AChE1a 3D
model revealed that the change from phenylalanine to
valine at position 318 resulted in a wider active-site
gorge (Figs. 5 and 6): the gorge of the V318 variant is
8% bigger than the gorge of the F318 variant. Phenyl-
alanine and valine have similar physical properties: both
are nonpolar, hydrophobic and have neutral charge, but
valine lacks the bulky aromatic ring of phenylalanine.
The docking analysis predicted that acetylcholine binds
in the active-site gorge of the F318 variant of C. roger-
cresseyi AChE1a in the proper place and orientation
[56]. Acetylcholine was also predicted to bind to the ac-
tive site of the V318 AChE1a variant. The organophos-
phates azamethiphos and dichlorvos were both
predicted to bind at the mouth of the active-site gorge
in the F318 variant. For azamethiphos in the V318 vari-
ant, the binding was predicted at both the mouth and
the bottom of the gorge, and for dichlorvos, only at the
mouth of the gorge.
The C. rogercresseyi AChE1b 3D model revealed a main
gorge in the center of the protein, as in other AChEs and
BChEs. The gorge is about 15 Å deep and 15 Å at its wid-
est point, and its entire volume is 33% bigger than the
gorge in C. rogercresseyi AChE1a F318 variant. Caligus
rogercresseyi AChE1b active-site gorge is 39% smaller than
human BChE. As stated above, the alignment of AChE1b
and AChE1a sequences showed that some of the ten im-
portant residues that characterize a typical AChE are
substituted by other amino acids in C. rogercresseyi
AChE1b (three residues of the catalytic triad and two resi-
dues of the acyl pocket) (Fig. 2). The alignment of
AChE1b and AChE1a in the 3D analysis showed that,
similar to AChE1a, the substituted amino acids in
AChE1b where also predicted at the bottom of the
AChE1b gorge (Additional files 6 and 8). Docking analysis
for AChE1b predicted that acetylcholine and azamethi-
phos bind inside the gorge. For dichlorvos, the analysis
predicted the binding at the mouth of the gorge.
Discussion
Decreased sensitivity of sea lice for various anti-lice che-
micals has become a major issue worldwide, with Chile
being no exception. Pyrethroids and emamectin benzoate
have been the major chemicals used aginst C. rogercresseyi
in Chile. However, the development of resistance over the
years, attributed to their overuse, has severely affected the
fish farm industry [7, 9–12]. Because of this increased re-
sistance, the organophosphate azamethiphos was intro-
duced in 2013 in order to improve delousing treatment
efficacies in the farms. Although azamethiphos treatments
provided a good delousing effect during 2013–2014 in
the four farms studied by Agusti et al. [7] (above 90%
Table 3 Percentage (%) of Caligus rogercresseyi carrying the F/V318
variant sampled before and after the azamethiphos field treatment
in Farm 3
Before treatment After treatment
Adult males 8.3 (1/12) 21.1 (4/19)
Younga males Not sampled 30 (3/10)
Maturea males 8.3 (1/12) 11.1 (1/9b)
Adult females 50 (9/18) 100 (8/8)
Younga females Not sampled 100 (8/8)
Maturea females 50 (9/18) Not found on fish
aYoung adults: adult lice with the genital segment not fully developed. Mature
adults: adult lice with fully developed genital segment [5]
bTen mature males recovered in total, but no sequence information from one
male due to poor RNA quality
The number of lice harboring the variant out of the total number of lice per
group is shown in parentheses
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treatment efficacy for adult lice), a loss of sensitivity
was reported using bioassays. Unfortunately, no mo-
lecular marker is yet available to identify resistance in
C. rogercresseyi due to the lack of knowledge on the
molecular mechanisms involved in resistance towards
the chemicals used. In the present study, we investi-
gated a possible molecular mechanism of azamethi-
phos sensitivity loss in C. rogercresseyi.
In order to elucidate the molecular mechanisms for re-
sistance, it is important to identify and characterize the
target proteins. As per the existing literature, AChEs are
the target proteins for organophosphates in arthropods
(reviewed in [24, 25, 28]). In the present study, we identi-
fied two AChEs in C. rogercresseyi, AChE1a and 1b. In C.
rogercresseyi AChE1a, the in silico analysis identified it as
an AChE with transmembrane region, and the alignment
with AChEs from other species showed that it has the
characteristic features of a main synaptic AChE [56]. The
AChE1a 3D model positioned the ten important amino
acids for the function of the protein at the bottom of the
gorge, and the docking analysis predicted acetylcholine to
bind at the proper site and orientation in the active-site
gorge [56]. The phylogenetic analysis revealed that
AChE1a clustered together with the AChE type 1 occur-
ring in several arthropods. These results strongly indicate
that AChE1a codes for the the main synaptic AChE. In
silico analysis of AChE1b identified it as an AChE without
transmembrane region, predicting the protein to be sol-
uble. The phylogenetic analysis clustered AChE1b to-
gether with other invertebrate AChEs belonging to type 1.
However, AChE1b lacks some of the important amino
acids for the function of a typical AChE. According to the
Table 4 3D modelling of Caligus rogercresseyi AChE1a (F318 and V318 variants) and AChE1b
Template Cr AChE1a (F318) Cr AChE1a (V318) Cr AChE1b
Hs AChE (4ey4.1) Dm AChE (1qo9.1) Hs AChE (4ey4.1) Dm AChE (1qo9.1) Hs BChE (4aqd.1)
GMQE 0.77 0.74 0.77 0.74 0.74
QMEAN -1.66 -3.91 -1.66 -3.91 -2.87
RSM wp (Å) 0.28 0.35 0.28 0.39 0.26
RSM 10 aa (Å) 0.13 0.34 0.13 0.23 0.25
Abbreviations: Cr Caligus rogercresseyi, Hs AChE recombinant human AChE in the apo state (PDB codes are shown in parentheses), Dm AChE native Drosophila
melanogaster AChE, Hs BChE fully glycosylated human butyrylcholinesterase, QMEAN and GMQE scores for the model quality, RMS (in Å) fit between template and
model (wp: whole protein; 10 aa: ten important amino acids)
Fig. 5 Overlay of the predicted 3D positioning of the ten functionally important amino acids in both Caligus rogercresseyi AChE1a variants. Numbering
corresponds to Caligus rogercresseyi AChE1a. The phenylalanine at position 318 (F290, Torpedo californica numbering) is displayed in green, while the
valine at that same position is in red
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docking analysis, C. rogercresseyi AChE1b could bind
acetylcholine, azamethiphos and dichlorvos at different
locations of the gorge. Enzymatic assays are necessary
in order to properly identify the function of C. roger-
cresseyi AChE1b, but a scavenger function is possible,
as is the case for vertebrate butyrylcholinesterase and
for some AChE soluble forms occuring in invertebrates.
In this respect, Kim et al. [58] described two AChEs in
the honeybee, a membrane-anchored enzyme with a
strong AChE activity and a soluble form with very low
AChE activity. The authors showed that the inhibition
of the main synaptic enzyme was reduced when inhibi-
tors were pre-incubated with the soluble form. In the
pinewood nematode, Kang et al. [59] also identified a
soluble AChE form that conferred protection against
anti-cholinesterase compounds.
Similar to C. rogercresseyi, two AChEs have been de-
scribed in the other sea lice affecting farmed salmonids,
L. salmonis [30]. These proteins were similar to each
other and both grouped together with other inverte-
brate AChEs type 1. They were named type 1a and 1b.
AChE1a was predicted to be the main synaptic AChE
in L. salmonis. AChE1b has also the typical AChE sig-
nature and the important amino acids for the function
of an AChE. It was predicted to be a soluble protein
and was suggested to be a functionally active AChE.
As per the existing literature, decreased sensitivity to-
wards organophosphates and carbamates is mostly associ-
ated with mutations in AChE genes in various arthropods
(reviewed in [25, 28]). Among these, point mutations are
the most commonly found. The majority of these mis-
sense mutations have been found in or around the active
gorge of the enzyme, making it a hot spot for mutations.
In order to correlate mutations or variants in AChE genes
with organophosphate resistance, it is essential to properly
characterize the sensitivity to the chemical of every single
parasite used in the analysis. Bioassays designed for
selecting individual lice are a reliable method to
accomplish this [21, 22]. In our study, lice immobilized
at 0.4 ppb or below were considered sensitive and lice
unaffected at 2 ppb, resistant [7, 19, 22, 23]. At the
louse population level, the bioassay performed in Farm
1 showed a louse sensitivity (EC50 ~0.5 ppb) close to
the C. rogercresseyi putative naïve level (~0.15 ppb, see
[7]). On the other hand, lice from Farm 2 showed
reduced sensitivity towards azamethiphos (EC50 1.2 ppb
and no lice immobilized at 0.8 ppb or below). For refer-
ence, L. salmonis resistant strains have EC50 values be-
tween 2.1 and 3.7 ppb (24 h bioassay) [19, 21].
The main synaptic C. rogercresseyi AChE, AChE1a, was
screened for variants in both azamethiphos-sensitive and
-resistant lice in the present study. One non-synonymous
change in the coding cDNA region, thymine to guanine at
position 952, was found in the two C. rogercresseyi individ-
uals surviving the highest azamethiphos concentration in
the bioassay. This nucleotide change led to the amino acid
change F318V (corresponding to F290 in T. californica
AChE). F290 (T. californica AChE numbering) is a com-
ponent part of the acyl pocket of AChE, which is respon-
sible for the ligand specificity, and it is highly conserved in
both AChE1 and AChE2 from various species, as shown
in Fig. 2. F318 (C. rogercresseyi AChE1a numbering) is
therefore an important residue, most likely playing an im-
portant role in the AChE function. Furthermore, F290 (T.
californica AChE numbering) has been observed as one of
the hot spots for mutations in AChE, conferring different
levels of resistance towards organophosphates and carba-
mates in various arthropods (reviewed in [25, 26, 28]).
The most common changes reported at that position are
F to V, F to L (leucine) or F to Y (tyrosine). Several exam-
ples illustrate the association between the F290V change
and organophosphate/carbamate resistant in arthropods.
The mutation F416V (F290V, T. californica numbering)
was found in organophosphate-resistant mosquitoes
Culex pipiens from Cyprus [60]. Interestingly, when the
authors introduced the F416V mutation in susceptible
Fig. 6 Surface of the predicted 3D structure of Caligus rogercresseyi AChE1a F318 variant (left panel, displayed on green) and V318 (right panel,
displayed on red). View from the mouth of the active-site gorge of the protein
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mosquitoes or in recombinant enzymes by site-directed
mutagenesis, they found similar levels of resistance to-
wards a range of organophosphates and carbamates when
compared to the naturally mutated resistant mosquitoes
[60, 61]. Resistant mosquitoes were homozygous for the
mutation, and the activity of the mutated V416 AChE1
was similar to the activity of the susceptible wild enzyme
(F416). The F416V mutation persisted for at least 16 years
in the mosquito population, and it was especially protect-
ive against the organophosphate dichlorvos. Interestingly,
salmonid fish infested with C. rogercresseyi had been
treated with dichlorvos for 15 years in the past in the
Chilean Los Lagos Region (1985–2000, reviewed in [8]).
The dichlorvos exposure may well have selected the C.
rogercresseyi AChE1a V318 variant in louse populations
in the past, conferring some protection for azamethi-
phos in the present.
The same residue of the acyl binding pocket was also
found mutated in other organophosphate and carbamate
resistant arthropods. For example, the change F399V
(homozygous) was reported in carbamate and organo-
phosphate resistant codling moth, Cydia pomonella [62].
In carbamate resistant striped rice stemborers, Chilo sup-
pressalis, the F402V variant was found alongside with four
other mutations in AChE1 (both heterozygous and homo-
zygous individuals were found) [63]. In the organophos-
phate resistant fall armyworm, Spodoptera frugiperda,
Carvalho et al. [26] found three amino acid substitutions
in the ace-1 gene, one of them being F290V (T. californica
numbering). Both heterozygous and homozygous individ-
uals were found for this mutation. Overexpression of sev-
eral genes was also found in organophosphate resistant
fall armyworms. In the organophosphate resistant dia-
mondback moth, Plutella xylostella, Yeh et al. [64] found
three amino acid substitutions in AChE1. One of them
was F386F/V (only heterozygous genotype was found).
Their 3D modeling showed that the F386V change en-
larges the space of the acetyl binding pocket. Our C. roger-
cresseyi AChE1a 3D model also revealed that the change
from phenylalanine to valine at position 318 results in a
wider active-site gorge.
The V318 variant in C. rogercresseyi AChE1a, has the
same ten important amino acids as vertebrate BChE, the
latter having valine or isoleucine (depending on the spe-
cies, see Additional file 9) in position 290 (T. californica
AChE numbering). Isoleucine and valine have similar bio-
chemical properties (conservative variation). Vertebrate
BChE has a wider substrate specificity than AChE, which
could also be the case for the C. rogercresseyi AChE1a
V318 variant. In invertebrates, Pezzementi et al. [65] in-
vestigated the acyl pocket of the amphioxus (Branchios-
toma floridae) cholinesterase type 2 (ChE2) by
site-directed mutagenesis. When the 312 phenylalanine of
the acyl pocket (B. floridae numbering; F290 T. californica
numbering) was replaced by isoleucine, a decrease in the
substrate specificity of the enzyme was observed. In
addition, the F312I mutation eliminated the substrate inhib-
ition by ACh. The docking analysis performed in the present
study showed that the F318V change in C. rogercresseyi
AChE1a could modify the binding properties of azamethi-
phos to the enzyme. Enzymatic assays are though warranted
in order to elucidate the activity of AChE1a V318 variant in
the presence and absence of organophosphates.
Only heterozygous C. rogercresseyi individuals were
found in our study. Several causes could explain the
lack of homozygous lice. When the frequency of the
variant in the population is low, the sample size must
be large to detect homozygous individuals. The per-
centage of males carrying the F/V318 variant sampled
before the azamethiphos field treatment in Farm 3 was
very low (8.3%) and the percentaje of females was 50%,
therefore the probability of finding homozygous indi-
viduals is low. The F318V change could also involve a
high fitness cost for the homozygous variant. However,
this change has been reported as homozygous in viable
resistant individuals in other arthropods (reported
earlier in the discussion). In our bioassays, one lice
carrying the F/V318 variant was immobilized at a low
azamethiphos concentration (Table 2). The heterozy-
gous variant may not provide full protection against
organophosphates, as shown by Kaur et al. [21, 22] in
L. salmonis.
In order to investigate the association between the
AChE1a F/V318 variant and azamethiphos sensitivity
loss, 57 C. rogercresseyi collected before and after an
azamethiphos field treatment were analysed. The ana-
lysis showed that every young adult female sampled
from the fish three days after treatment carried the F/
V318 variant (Table 3). These results indicate that the F/
V318 variant plays an important role in protecting C.
rogercresseyi against azamethiphos. However, other
mechanisms could also be involved in the protection,
since lice not carrying the F/V318 variant were un-
affected at 1.2 ppb azamethiphos in the bioassays (Table
2). Behavioral avoidance, differences in the expression of
the acetylcholinesterases and/or in the genes coding for
detoxifying enzymes could contribute to the lice survival
to azamethiphos exposure, as observed in other arthro-
pods (reviewed in [24, 26–28]). Mobile small lice can
hide under the scales of the fish, becoming less exposed
to the bath treatment (C. Agusti and S. Bravo personal
observation). In Farm 3, adult males without the F/V318
variant were found after the treatment. Mature adult
males have higher mobility than adult females with fully
developed genital segment. The post-treatment sampling
occurred three days after the azamethiphos treatment,
thus the mature adult males found post-treatment could
be lice arriving from other untreated cages or farms.
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In L. salmonis, azamethiphos is considered to have a
poorer effect against the two chalimus stages compared to
preadult and adult stages. In the present study with C.
rogercresseyi, which has four chalimus stages, 57% efficacy
was recorded for chalimus. This figure should be inter-
preted with caution as the first two chalimus stages are
difficult to see and count correctly. Within the three days
from treatment to sampling, some of the chalimus IV
could have moulted to young adults. Still, if the survival of
the treatment was independent of the F/V318 variant, an
equal proportion of F318 and F/V318 would be expected
in the surviving parasites, but instead 100% of the young
females sampled after treatment had the F/V318 variant.
Moreover, both young adult lice (one male and one fe-
male) unaffected at 2 ppb azamethiphos in the bioassay,
were carrying the F/V318 variant.
Caligus rogercresseyi resistance towards azamethiphos
is emerging and developing in Chile. In general, several
resistance mechanisms can arise while resistance is
developing. Although different mechanisms could be
involved in the lice protection against azamethiphos,
the AChE1a F/V318 variant is most probably playing a
significant role in the observed reduced sensitivity. The
variant could therefore be a good candidate as molecu-
lar marker, indicating loss of sensitivity in C. rogercres-
seyi towards organophosphates in Chile.
Conclusions
The present study reports for the first time the identifica-
tion and characterization of two AChEs in C. rogercresseyi.
AChE1a is most likely the main synaptic AChE, whereas
AChE1b could be a scavenger protein. We found one vari-
ant (F/V318) in C. rogercresseyi AChE1a that could play a
role in making the parasite less sensitive to azamethiphos.
This change has been reported to be conferring resistance
in several other arthropods towards organophosphates
and carbamates. An azamethiphos field treatment showed
a selection of the F/V318 variant after treatment among
young adult females, indicating an association between
the presence of the variant and the survival of C. rogercres-
seyi to azamethiphos. Future screening in a larger sea lice
population is warranted to validate this.
Additional files
Additional file 1: Primers used for amplifying and sequencing the
Caligus rogercresseyi AChE sequences found in this study. (PDF 16 kb)
Additional file 2: Caligus rogercresseyi AChE sequences in Whole-Genome
Shotgun: contigs. (PDF 6 kb)
Additional file 3: Full list of abbreviations and UniprotKB database entry
names from data used in Figs. 2 and 4 and Additional file 4. (PDF 21 kb)
Additional file 4: Phylogenetic analysis including Caligus rogercresseyi
AChE1a and AChE1b together with several invertebrate and vertebrate
carboxylesterases, esterases and other cholinesterases. Crustacean
proteins are shown in red letters. Branches in red correspond to proteins
tentatively assigned to the AChE type in the present analysis. For
abbrevations and UniprotKB database entry names see Additional file 3.
(PDF 170 kb)
Additional file 5: Alignment of the full coding ace1a cDNA sequence
from 10 Caligus rogercresseyi. The lack of the star symbol under the
sequences indicates a SNP. Every individual is represented by the two
cDNA variants (a and b), according to the SNPs found. Individual louse
code: resistant (LR1, LR2), reduced sensitivity (AL, BL, CL), sensitive (SS1,
S1, S2, S3, S4). (PDF 118 kb)
Additional file 6: PDB file of the predicted 3D structure of Caligus
rogercresseyi AChE1a F318 variant. Viewer: UCSF Chimera 1.10.2. software.
https://www.cgl.ucsf.edu/chimera. (PDB 342 kb)
Additional file 7: PDB file of the predicted 3D structure of Caligus
rogercresseyi AChE1a V318 variant. Viewer: UCSF Chimera 1.10.2. software.
https://www.cgl.ucsf.edu/chimera. (PDB 331 kb)
Additional file 8: PDB file of the predicted 3D structure of Caligus
rogercresseyi AChE1b. Viewer: UCSF Chimera 1.10.2. software. https://
www.cgl.ucsf.edu/chimera. (PDB 296 kb)
Additional file 9: Alignment of six vertebrate butyrylcholinesterases
(BChE), Caligus rogercresseyi AChE1a V318 variant (M) and Caligus
rogercresseyi AChE1b. Figure showing a fragment of the alignment
containing the amino acid corresponding to the position F290 (Torpedo
californica AChE numbering) (highlighted). (PDF 165 kb)
Abbreviations
3D: Three-dimensional; AChE: Acetylcholinesterase enzyme;
ChE: Cholinesterase enzyme; EC50: The concentration of a chemical
immobilizing 50% of the parasites; F318F/V: The important change found in
the amino acid sequence in the main synaptic Caligus rogercresseyi AChE
(AChE1a); Ki: Concentration required to produce half-maximum inhibition
(docking analysis); MCMC: Markov Chain Monte Carlo analysis; MSA: Multiple
Sequence Alignment; ORF: Open reading frame of a gene; ppb: μg l-1;
QMEAN and GMQE: Global 3D model quality estimation scores; RMS: Root
mean square value for carbon alpha (Cα) used for analyzing the fit between
the selected templates and the predicted AChEs structures in the 3D
analysis; UTR: Untranslated region of a gene; WGS: Whole-Genome Shotgun
Acknowledgements
We thank the staff at the fish farms (veterinarians, farm managers, farm
operators) of Cermaq Chile, and especially to Cristina Winkler and Ingrid
Ojeda for their assistance in the louse collection and providing all necessary
data. We acknowledge Felipe Kauak, Karla Sambra and Nike Ponce for their
assistance in the lice collection and performing of bioassays. We also thank
Melanie Andrews for the language corrections and Patricia Gozalbes-Aparicio
for the map design in Fig. 1. We sincerely thank the comments and sugges-
tions made by the anonymous referees since they substantially improved
the manuscript.
Funding
During the development of the study, the first author held a post-doctoral
research fellowship from the Research Council of Norway, HAVBRUK program,
project number: 234060/E40. This work was partially funded by the SFI-Sea Lice
Research Centre, grant number 203513/030. The funding body had no role in
the design of the study, collection, analysis, interpretation of data or in writing
the manuscript.
Availability of data and materials
Most data generated or analyzed during this study are included in this
published article and its additional files. Additional data are available from
the corresponding author upon reasonable request.
Authors’ contributions
CAR and TEH were involved in the planning of the study, interpretation of
the results and in writing the manuscript. CAR peformed most of the louse
sampling and bioassays, as well as most of the molecular analysis. MD and
KK performed some molecular analyisis and contributed in writing the
manuscript. JL and BK contributed in the molecular analysis. SB and JM
assisted in the organization and performance of the lice sampling and
bioassays. All authors read and approved the final manuscript.
Agusti-Ridaura et al. Parasites & Vectors          (2018) 11:570 Page 14 of 16
Ethics approval and consent to participate
The study only involved sea lice and no fish were used. All parasites were
collected from fish farms with the farmers’ consent, after which no further





The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Faculty of Veterinary Medicine, Norwegian University of Life Sciences, Sea
Lice Research Centre, Postboks 369 Sentrum, Oslo NO-0102, Norway.
2Department of Informatics, University of Bergen, Sea Lice Research Centre,
Thormøhlensgate 55, N-5008 Bergen, Norway. 3Biology Department, Centre
for Biomedical Research, University of Victoria, Station CSC, PO Box 1700,
Victoria, BC V8W 2Y2, Canada. 4Universidad Austral de Chile, Casilla 1327,
Puerto Montt, Chile. 5Cermaq Chile, Diego Portales 2000, Puerto Montt, Chile.
Received: 19 June 2018 Accepted: 14 October 2018
References
1. Bravo S. Sea lice in Chilean salmon farms. Bull Eur Assoc Fish Pathol. 2003;
23:197–200.
2. Johnson SC, Treasurer JW, Bravo S, Nagasawa K. Kabata Z. A review of the
impact of parasitic copepods on marine aquaculture. Zool Stud. 2004;43:
229–43.
3. Lhorente JP, Gallardo JA, Villanueva B, Carabaño MJ, Neira R. Disease
resistance in Atlantic salmon (Salmo salar): coinfection of the intracellular
bacterial pathogen Piscirickettsia salmonis and the sea louse Caligus
rogercresseyi. PLoS One. 2014;9:e95397.
4. González MP, Muñoz JLP, Valerio V, Vargas-Chacoff L. Effects of the
ectoparasite Caligus rogercresseyi on Salmo salar blood parameters under
farm conditions. Aquaculture. 2016;457:29–34.
5. González L, Carvajal J. Life cycle of Caligus rogercresseyi, (Copepoda: Caligidae)
parasite of Chilean reared salmonids. Aquaculture. 2003;220:101–17.
6. Aaen SM, Helgesen KO, Bakke MJ, Kaur K, Horsberg TE. Drug resistance in
sea lice: a threat to salmonid aquaculture. Trends Parasitol. 2015;31:72–81.
7. Agusti C, Bravo S, Contreras G, Bakke MJ, Helgesen KO, Winkler C, et al.
Sensitivity assessment of Caligus rogercresseyi to anti-louse chemicals in
relation to treatment efficacy in Chilean salmonid farms. Aquaculture. 2016;
458:195–205.
8. Bravo S, Sepulveda M, Silva MT, Costello MJ. Efficacy of deltamethrin in the
control of Caligus rogercresseyi (Boxshall and Bravo) using bath treatment.
Aquaculture. 2014;432:175–80.
9. Bravo S, Sevatdal S, Horsberg TE. Sensitivity assessment of Caligus
rogercresseyi to emamectin benzoate in Chile. Aquaculture. 2008;282:7–12.
10. Bravo S, Sevatdal S, Horsberg TE. Sensitivity assessment in the progeny of
Caligus rogercresseyi to emamectin benzoate. Bull Eur Assoc Fish Pathol.
2010;30:92–8.
11. Bravo S, Silva MT, Monti G. Efficacy of emamectin benzoate in the control of
Caligus rogercresseyi on farmed Atlantic salmon (Salmo salar L.) in Chile from
2006 to 2007. Aquaculture. 2012;364–365:61–6.
12. Helgesen KO, Bravo S, Sevatdal S, Mendoza J, Horsberg TE. Deltamethrin
resistance in the sea louse Caligus rogercresseyi (Boxhall and Bravo) in Chile:
bioassay results and usage data for antiparasitic agents with references to
Norwegian conditions. J Fish Dis. 2014;37:877–90.
13. Sernapesca. Informe Sanitario de Salmonicultura en Centros Marinos. 2016.
http://www.sernapesca.cl. Accessed 19 Sept 2017.
14. Denholm I, Devine GJ, Horsberg TE, Sevatdal S, Fallang A, Nolan DV, et al.
Analysis and management of resistance to chemotherapeutants in salmon
lice Lepeophtheirus salmonis (Krøyer) (Copepoda: Caligidae). Pest Manag Sci.
2002;58:528–36.
15. Jones MW, Sommerville C, Wootten R. Reduced sensitivity of the salmon
louse, Lepeophtheirus salmonis, to the organophosphate dichlorvos. J Fish
Dis. 1992;15:197–202.
16. Roth M, Richards RH, Dobson DP, Rae GH. Field trials on the efficacy of the
organophosphorus compound azamethiphos for the control of sea lice
(Copepoda: Caligidae) infestations of farmed Atlantic salmon (Salmo salar).
Aquaculture. 1996;140:217–39.
17. Tully O, McFadden Y. Variation in sensitivity of sea lice Lepeophtheirus
salmonis (Krøyer) to dichlorvos on Irish salmon farms in 1991–92. Aquac Res.
2000;31:849–54.
18. Marín SL, Ibarra R, Medina MH, Jansen PA. Sensitivity of Caligus rogercresseyi
(Boxshall and Bravo 2000) to pyrethroids and azamethiphos measured using
bioassay tests - a large scale spatial study. Prev Vet Med. 2015;122:33–41.
19. Helgesen KO, Horsberg TE. Single-dose field bioassay for sensitivity testing
in sea lice, Lepeophtheirus salmonis: development of a rapid diagnostic tool.
J Fish Dis. 2013;36:261–72.
20. Robertson JL, Preisler HK, Ng SS, Hickle LA, Gelernter WD. Natural variation:
a complicating factor in bioassays with chemical and microbial pesticides. J
Econ Entomol. 1995;88:1–10.
21. Kaur K, Helgesen KO, Bakke MJ, Horsberg TE. Mechanism behind resistance
against the organophosphate azamethiphos in salmon lice (Lepeophtheirus
salmonis). PLoS One. 2015b;10:e0124220.
22. Kaur K, Jansen PA, Aspehaug VT, Horsberg TE. Phe362Tyr in AChE: A major
factor responsible for azamethiphos resistance in Lepeophtheirus salmonis in
Norway. PLoS One. 2016;11:e0149264.
23. Jansen PA, Grøntvedt RN, Tarpai A, Helgesen KO, Horsberg TE. Surveillance
of the sensitivity towards antiparasitic bath-treatments in the salmon louse
(Lepeophtheirus salmonis). PLoS One. 2016;11:e0149006.
24. Siegfried BD, Scharf ME. Mechanisms of organophosphate resistance in
insects. In: Ishaaya I, editor. Biochemical sites of insecticide action and
resistance. Heidelberg-Berlin: Springer; 2001. p. 269–91.
25. Hotelier T, Nègre V, Marchot P, Chatonnet A. Insecticide resistance through
mutations in cholinesterases or carboxylesterases: data mining in the
ESTHER database. J Pestic Sci. 2010;35:315–20.
26. Carvalho RA, Omoto C, Field LM, Williamson MS, Bass C. Investigating the
molecular mechanisms of organophosphate and pyrethroid resistance in
the fall armyworm Spodoptera frugiperda. PLoS One. 2013;8:e62268.
27. Nansen C, Baissac O, Nansen M, Powis K, Baker G. Behavioral avoidance -
will physiological insecticide resistance level of insect strains affect their
oviposition and movement responses? PLoS One. 2016;11:e0149994.
28. Guo D, Luo J, Zhou Y, Xiao H, He K, Yin C, et al. ACE: an efficient and
sensitive tool to detect insecticide resistance-associated mutations in insect
acetylcholinesterase from RNA-Seq data. BMC Bioinformatics. 2017;18:330.
29. Toutant JP. Insect acetylcholinesterase: catalytic properties, tissue
distribution and molecular forms. Prog Neurobiol. 1989;32:423–46.
30. Kaur K, Bakke MJ, Nilsen F, Horsberg TE. Identification and molecular
characterization of two acetylcholinesterases from the salmon louse,
Lepeophtheirus salmonis. PLoS One. 2015a;10:e0125362.
31. Leong JS, Bravo S, von Schalburg KR, Koop BF. Caligus rogercresseyi
transcriptome shotgun assembly (TSA) (11.09.2014). GenBank number:
GAZX00000000.1. Centre for Biomedical Research, University of Victoria,
Canada. 2014. https://www.ncbi.nlm.nih.gov/nuccore/604768531. Accessed
19 Sept 2017.
32. NCBI, National Center for Biotechnology Information. Basic Local Alignment
Search Tool. http://blast.ncbi.nlm.nih.gov. Accessed 19 Sept 2017.
33. Leong JS, Rondeau EB, Koop BF. Caligus rogercresseyi whole-genome
shotgun contigs (WGS). GenBank numbers: LBBV00000000.1 (female; 08.05.
2015) and LBBU00000000.1 (male; 07.05.2015). Centre for Biomedical
Research, University of Victoria, Canada. 2015. https://www.ncbi.nlm.nih.gov/
nuccore/LBBV00000000.1; https://www.ncbi.nlm.nih.gov/nuccore/819231677.
Accessed 19 Sept 2017.
34. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, et al. Fast, scalable
generation of high-quality protein multiple sequence alignments using
Clustal Omega. Mol Syst Biol. 2011;7:539.
35. Hirokawa T, Boon-Chieng S, Mitaku S. SOSUI: classification and secondary
structure prediction system for membrane proteins. Bioinformatics. 1998;14:378–9.
36. SOSUI system. http://harrier.nagahama-i-bio.ac.jp/sosui/sosui_submit.html
(Accessed 19 Sept 2017).
37. Sonnhammer EL, von Heijne G, Krogh A. A hidden Markov model for
predicting transmembrane helices in protein sequences. Proc Int Conf Intell
Syst Mol Biol. 1998;6:175–82.
Agusti-Ridaura et al. Parasites & Vectors          (2018) 11:570 Page 15 of 16
38. TMHMM Server v. 2.0. http://www.cbs.dtu.dk/services/TMHMM/
(Accessed 19 Sept 2017).
39. Krogh A, Larsson B, von Heijne G, Sonnhammer ELL. Predicting
transmembrane protein topology with a hidden Markov Model: application
to complete genomes. J Mol Biol. 2001;305:567–80.
40. Cserzo M, Wallin E, Simon I, Von Heijne G, Elofsson A. Prediction of
transmembrane alpha-helices in procariotic membrane proteins: the Dense
Alignment Surface method. Prot Eng. 1997;10:673–6.
41. “DAS” - Transmembrane Prediction server. https://tmdas.bioinfo.se/DAS/
(Accessed 19 Sept 2017).
42. Edgar RC. MUSCLE: Multiple sequence alignment with high accuracy and
high throughput. Nucl Acids Res. 2004;32:1792–7.
43. Clamp M, Cuff J, Searle SM, Barton GJ. The Jalview Java Alignment Editor.
Bioinformatics. 2004;20:426–7.
44. Huelsenbeck JP, Ronquist F. MRBAYES: Bayesian inference of phylogenetic
trees. Bioinformatics. 2001;17:754–5.
45. Ronquist F, Huelsenbeck JP. MrBayes 3: Bayesian phylogenetic inference
under mixed models. Bioinformatics. 2003;19:1572–4.
46. Abascal F, Zardoya R, Posada D. ProtTest: Selection of best-fit models of
protein evolution. Bioinformatics. 2005;21:2104–5.
47. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a
web-based environment for protein structure homology modelling.
Bioinformatics. 2006;22:195–201.
48. Bordoli L, Kiefer F, Arnold K, Benkert P, Battey J, Schwede T. Protein
structure homology modelling using SWISS-MODEL workspace. Nat
Protoc. 2009;4:1–13.
49. Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T,
Kiefer F, et al. SWISS-MODEL: modelling protein tertiary and
quaternary structure using evolutionary information. Nucleic Acids
Res. 2014;42:W252–8.
50. Guex N, Peitsch MC, Schwede T. Automated comparative protein structure
modeling with SWISS-MODEL and Swiss-PdbViewer: A historical perspective.
Electrophoresis. 2009;30:S162–73.
51. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC,
et al. UCSF Chimera--a visualization system for exploratory research and
analysis. J Comput Chem. 2004;25:1605–12.
52. Dundas J, Ouyang Z, Tseng J, Binkowski A, Turpaz Y, Liang J. CASTp:
computed atlas of surface topography of proteins with structural and
topographical mapping of functionally annotated residues. Nucl Acids Res.
2006;34:W116–8.
53. CASTp server. http://sts.bioe.uic.edu/castp (Accessed 19 Sept 2017).
54. Bikadi Z, Hazai E. Application of the PM6 semi-empirical method to
modeling proteins enhances docking accuracy of AutoDock. J Cheminform.
2009;1:15.
55. Dockingserver. http://www.dockingserver.com/web (Accessed 19 Sept
2017).
56. Dvir H, Silman I, Harel M, Rosenberry TL, Sussman JL. Acetylcholinesterase:
from 3D structure to function. Chem Biol Interact. 2010;187:10–22.
57. Harel M, Kryger G, Rosenberry TL, Mallender WD, Lewis T, Fletcher RJ, et al.
Three-dimensional structures of Drosophila melanogaster
acetylcholinesterase and of its complexes with two potent inhibitors.
Protein Sci. 2000;9:1063–72.
58. Kim YH, Cha DJ, Jung JW, Kwon HW, Lee SH. Molecular and kinetic
properties of two acetylcholinesterases from the western honey bee, Apis
mellifera. PLoS One. 2012;7:e48838.
59. Kang JS, Lee DW, Koh YH, Lee SH. A soluble acetylcholinesterase provides
chemical defense against xenobiotics in the pinewood nematode. PLoS
One. 2011;6:e19063.
60. Alout H, Berthomieu A, Hadjivassilis A, Weill M. A new amino-acid
substitution in acetylcholinesterase 1 confers insecticide resistance
to Culex pipiens mosquitoes from Cyprus. Insect Biochem Molec.
2007;37:41–7.
61. Alout H, Weill M. Amino-acid substitutions in acetylcholinesterase 1
involved in insecticide resistance in mosquitoes. Chem Biol Interact. 2008;
175:138–41.
62. Cassanelli S, Reyes M, Rault M, Manicardi GC, Sauphanor B.
Acetylcholinesterase mutation in an insecticide-resistant population of the
codling moth Cydia pomonella (L.). Insect Biochem Molec. 2006;36:642–53.
63. Chang C, Cheng X, Huang XY, Dai SM. Amino acid substitutions of
acetylcholinesterase associated with carbofuran resistance in Chilo
suppressalis. Pest Manag Sci. 2014;70:1930–5.
64. Yeh S, Lin C, Chang C, Feng H, Dai S. Amino acid substitutions and intron
polymorphism of acetylcholinesterase1 associated with mevinphos
resistance in diamondback moth, Plutella xylostella (L.). Pestic Biochem Phys.
2014;112:7–12.
65. Pezzementi L, Johnson K, Tsigelny I, Cotney J, Manning E, Barker A, et al.
Amino acids defining the acyl pocket of an invertebrate cholinesterase.
Comp Biochem Physiol. 2003;136:813–32.
Agusti-Ridaura et al. Parasites & Vectors          (2018) 11:570 Page 16 of 16
